PUBLISHER: Allied Market Research | PRODUCT CODE: 1472183
PUBLISHER: Allied Market Research | PRODUCT CODE: 1472183
The microbial identification market was valued at $3.5 billion in 2022 and is projected to reach $6.4 billion by 2032, registering a CAGR of 6.2% from 2023 to 2032. Microbial identification is the process of determining the specific types of microorganisms present in a given sample, such as bacteria, viruses, fungi, or protozoa. This scientific endeavor is crucial in various fields, including microbiology, medicine, environmental science, and food safety. The identification of microbes involves analyzing their morphological, biochemical, and genetic characteristics to classify and differentiate them. Traditional methods include microscopy, culture techniques, and biochemical tests, while modern advancements utilize molecular biology techniques such as DNA sequencing and polymerase chain reaction (PCR).
Accurate microbial identification is essential for understanding the role of microorganisms in various environments, diagnosing infectious diseases, ensuring food and water safety, and developing targeted treatments or preventive measures. Advances in technology continue to enhance the precision and speed of microbial identification, contributing to the broader understanding of microbial diversity and their impact on health and ecosystems.
The growing incidence of infectious diseases globally is a major driver for the microbial identification market. As infections become more common and widespread, there is an urgent need for timely and accurate diagnosis to guide treatment decisions and enable effective public health response. Advanced microbial identification products that can quickly detect pathogens and analyze their genomic makeup to identify drug resistance and strain variations have become critical tools for tackling this major health threat. In addition, rise in technological advancements in microbial identification methods, such as DNA sequencing, mass spectrometry, and polymerase chain reaction (PCR), have enhanced the speed and accuracy of pathogen identification, which is expected to drive the market growth. These innovations have become invaluable tools in clinical laboratories, aiding in the timely detection and characterization of infectious agents. Furthermore, surge in awareness about early disease diagnosis among the general population has increased the demand for microbial identification tests. Awareness campaigns, educational seminars, and training programs emphasize the importance of early disease diagnosis. For instance, F. Hoffmann-La Roche Ltd. supports local community partners to run screening programs and counselling programs for diseases such as cancers, hepatitis, tuberculosis, HIV, HPV, and cardiovascular disease.
Moreover, ongoing research and development efforts in microbiology and infectious diseases lead to the introduction of new and improved microbial identification methods, which further support market growth. Ongoing research and development efforts contribute to the development of more accurate, rapid, and cost-effective methods, addressing the evolving needs of diverse industries such as healthcare, food safety, and environmental monitoring. These initiatives not only enhance the capabilities of microbial identification but also lead to the introduction of novel techniques, which are expected to drive market growth.
However, lack of skilled laboratory technicians is anticipated to hinder the market growth. The shortage of skilled personnel in some regions or facilities may impede the effective utilization of these technologies, leading to underutilization or misinterpretation of results, which negatively impacted the market growth. In contrast, the rise in the number of diagnostic testing and technological advancements microbial identification tests are expected to create lucrative opportunities for market growth during the forecast period.
The microbial identification market is segmented on the basis of product and service, method, technology, end user, and region. By product and service, the market is classified into instruments, consumables, and services. By method, the market is divided into phenotypic method, genotypic method, and proteomic method. By technology the market is divided into mass spectrometry, PCR, flow cytometry, and others. By end user, it is segregated into food and beverage industry, pharmaceutical and biotechnological industry, environmental water industry, and others.
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA). Major key players that operate in the microbial identification market are BIOMERIEUX, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc, Bruker Corporation, Charles River Laboratories, Danaher Corporation, Merck KGaA, QIAGEN, Shimadzu Corporation, and Thermo Fisher Scientific Inc.
Key players have adopted acquisition, partnership, agreement, product approval and product launch as key developmental strategies to improve the product portfolio of the microbial identification market. For instance, in March 2022, bioMerieux, a world leader in the field of in vitro diagnostics, announced that VITEK MS PRIME, its new MALDI-TOF mass spectrometry identification system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Key Benefits for Stakeholders
Additional benefits you will get with this purchase are:
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)